UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £142.00. The ...
Great Britain claim a historic one-two at the skeleton World Championships as Matt Weston wins gold for a second time.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results